Q1 FY27 saw strong revenue growth, with 146 net new stores and diagnostics revenue up YoY. Gross margins declined due to lower private label mix and higher franchisee contribution, but management expects recovery in coming quarters. CapEx for non-core projects is on hold following investor feedback.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.